AGYS Form 4: CFO reports 5,330 RSUs under 2024 equity plan

Rhea-AI Filing Summary

Agilysys (AGYS) reported an insider equity grant. The Chief Financial Officer filed a Form 4 disclosing 5,330 restricted stock units granted on 11/03/2025 under the Agilysys, Inc. 2024 Equity Incentive Plan. Each unit represents the right to receive one share of common stock.

The RSUs vest in one‑third increments on 10/31/2026, 10/31/2027, and 10/31/2028. Following the transaction, the officer beneficially owns 8,007 derivative securities as reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wood William David III

(Last) (First) (Middle)

C/O AGILYSYS, INC.

3655 BROOKSIDE PARKWAY, SUITE 300

(Street)

ALPHARETTA GA 30022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AGILYSYS INC [ AGYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	11/03/2025		A		5,330		(2)	(2)	Common Stock	5,330	$0	8,007	D

Explanation of Responses:

1. Restricted stock units granted under the Agilysys, Inc. 2024 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock of Agilysys, Inc.

2. The restricted stock units vest in one-third increments on October 31, 2026, 2027 and 2028.

	/s/ Kyle C. Badger, Attorney-in-Fact	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Agilysys (AGYS) report in this Form 4?

The CFO reported a grant of 5,330 restricted stock units on 11/03/2025.

Who is the reporting person and their role at AGYS?

The reporting person is the company’s Chief Financial Officer.

How do the 5,330 RSUs vest for AGYS?

They vest in one‑third increments on 10/31/2026, 10/31/2027, and 10/31/2028.

Under which plan were the RSUs granted at AGYS?

They were granted under the Agilysys, Inc. 2024 Equity Incentive Plan.

What does each RSU represent in the AGYS filing?

Each RSU represents a contingent right to receive one share of common stock.

How many derivative securities does the officer own after this grant?

The filing reports 8,007 derivative securities beneficially owned following the transaction.

Was there a price listed for the RSUs in the AGYS filing?

Yes. The price of the derivative security is shown as $0.